Black Diamond Therapeutics
BDTX
BDTX
80 hedge funds and large institutions have $968M invested in Black Diamond Therapeutics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+15
Holders Change %
+23.08%
% of All Funds
1.64%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
20
Increased
29
Reduced
13
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Wells Fargo
San Francisco,
California
|
+$11.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.54M |
| 3 |
BlackRock
New York
|
+$7.79M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$7.49M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.85M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.88M |
| 2 |
AG
Artal Group
Luxembourg
|
-$6.32M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$4.29M |
| 4 |
Goldman Sachs
New York
|
-$3.08M |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.13M |
